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unIVeRsal HPlc analYsIs foR counteRfeIt meDIcatIon:
A Partnership of Purdue University and the Kilimanjaro School of Pharmacy

Jordyn McCord, Michael Mavity, Shanygne Ashley Damayo, College of Engineering,
and David Wintczak, College of Pharmacy

ABSTRACT
Counterfeit drugs pose a serious problem in Tanzania and
other countries in Africa. These drugs are very similar to
the real product in size, shape, and packaging. However,
counterfeit drugs have less to none of the active
pharmaceutical ingredient, rendering them essentially
useless. Patients and medical practitioners often are
unable to distinguish between the real medication and the
counterfeit version, meaning that a patient’s condition
may go untreated. Research conducted by the Global
Development Team is aimed at developing a simple way
to distinguish between real and counterfeit drugs, as well
as to develop a universal method that can systematically
analyze a wide variety of drug compounds. Purdue
students describe the development of training materials
and plans to travel to the Kilimanjaro School of
Pharmacy in Tanzania to educate students and faculty on
how to utilize this method.

diseases were attributed to the falsification of nearly onequarter of all pharmaceuticals, according to the World
Health Organization (Bagozzi, 2003). With such high
incidence of substandard medication, many patients have
developed a strong distrust in pharmaceuticals.

INTRODUCTION

One method to combat the counterfeit drug problem
includes paper analytical devices (PADs) created by
scientists at the University of Notre Dame (Rosenwald,
2013). These strips of paper quickly detect whether a
medication is counterfeit. They are easy to distribute
and use, making them popular. Unfortunately, each
PAD must be specific to each drug and the strips are
not strong indicators of how much of the API is present
in the product. Results from this project could be used
to confirm the actual percent of active drug product in
a compound, while the PADs give a broad indication
of whether it is counterfeit. Additional devices such as
the Zaman’s PharmaCheck are able to indicate relative
percent of active drug product, but also are specific to
each drug (Dwortzan, 2013).

It is important that patients actually receive the
medication that they were prescribed. Many Western
cultures take this for granted, but in other parts of the
world there is a serious problem with patients receiving
counterfeit drugs. Countless lives have been lost due
to ineffective treatment of diseases or consumption of
potentially harmful substances. The U.S. Food and Drug
Administration estimates that approximately 450,000
malarial deaths worldwide are the result of counterfeit
medication (Karunamoorthi, 2014). It has been estimated
that in the developing world, preventable deaths and

The Global Development Team, led by Drs. Stephen
Byrn and Kari Clase (Purdue University three-credit
course: GEP 40000), aims to develop a universal
method for detecting counterfeit medications.
Engineering and pharmacy students work together on
this interdisciplinary project in this course. The project
partner is the Kilimanjaro School of Pharmacy in
Tanzania. When developed, this method will encompass
a variety of medications rather than one procedure per
each drug type. The project partner could test multiple
drugs quickly and effectively. Ongoing goals of the
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project will be to create methods for an increasing
number of drug products, assemble operational detection
instruments including software and computers, and
develop training materials to implement the project at
the Kilimanjaro School of Pharmacy in Tanzania.
METHODOLOGY
In order to determine which drugs to initially focus
on, the team studied the World Health Organization’s
(WHO) essential medicines list. The next consideration
was the relevance of the drugs in Tanzania. To find
out which pharmaceuticals were often used, the
team researched common diseases and associated
prescriptions in the area. We also examined drugs
cited as most often counterfeited in Tanzania. After
determining a list of possible drugs to test, the project
advisors and partners were consulted for additional
insight into which drugs should be considered for
preliminary analysis. Five drugs of varied indications
were selected to develop a basic detection method:
amoxicillin, hydrochlorothiazide, lumefantrine,
mefloquine, and quinine.
There are numerous methods for detecting the presence
of specific chemicals within a compound, including
thin-layer chromatography, mass spectrometry, gas
chromatography, and many others. High-performance
liquid chromatography (HPLC) is one of the most
common and sensitive analytical techniques used in the
pharmaceutical industry and is a quality metric in most
industrial chemical production facilities. It works by
separating compounds through a pressurized column
based on their physical properties, such as lipophilicity
and polarity. HPLC was chosen as the basis for this work
because the variables can be manipulated in such a way
that an almost unlimited number of drugs can be tested
and identified. This option also allows for all five of the
selected drugs to be analyzed utilizing very few additional
resources. Agilent 1100 series HPLC instruments and
software packages travel well and were provided through
the generous donation of Merck & Co., Inc. (Figure 1).
The United States Pharmacopeia (USP) is responsible
for setting and publishing the standards for testing the
quality of all medications. The USP contains verified
methods for analyzing drugs, including the quantified
best HPLC procedures for each of the five drugs
tested by this team. While these methods are both
accurate and ideal, they often are very different for
each medication. The team initially performed the USP
protocol for each of the five drugs being considered
to verify HPLC methods and instruments. We noticed
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that a select few common solvents and columns were
used for the different methods. The team used this
information and the available materials to determine that
the Agilent Zorbax SB C18 column would be applied
to all procedures. This column was readily available
in the lab and is a common size and type of column.
Later testing indicates that this column is suitable for
the methods developed in the project. The commonality
in USP protocols also helped the team decide to focus
universal efforts on creating methods using three select
solvents: methanol, acetonitrile, and 0.05 M monobasic
potassium phosphate. Extraction procedures are in
development for each of the five drugs being studied.
These will allow the instrument to output values for the
active pharmaceutical ingredient, if it is present, and will
eliminate most excipients in the full drug products that
function to stabilize and deliver the medication but that
are not relevant to this project.
Methods for assembling the provided HPLC instrument
are in development. The team also is creating training
materials and a troubleshooting guide for the students
and staff at the Kilimanjaro School of Pharmacy.
BRIEF RESULTS
The team had to alter USP protocol to comply with
the project’s three-solvent system. Most USP methods
require some form of salt, which was replaced with
the potassium phosphate buffer in all of the project
methods. Results indicate that these replacements still
generate acceptable responses as indicated in sample
chromatograms found in Figures 2 and 3.
The potassium phosphate solvent has been studied at
varied pH levels and has thus far shown acceptable
results for four of the five drugs when the natural pH

Figure 1. High-performance liquid chromatography unit at the
Kilimanjaro School of Pharmacy.
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Figure 2. HPLC chromatogram for USP-grade amoxicillin using the developed universal method indicates a significant peak at
approximately a 5.5 minute elution time, indicating purity and efficacy of the method.

Figure 3. HPLC chromatogram for USP-grade hydrochlorothiazide using the developed universal method indicates a significant peak at
approximately a 15.4 minute elution time, indicating purity and efficacy of the method.

level is used. This is ideal because it lowers cost and
time required for creating the buffer. All methods for the
five pure drug compounds using the project’s universal
approach have been verified. Methods for extraction are
developed and in process of verification.

FUTURE WORK
In order to further fulfill the goals of this project,
members of this Global Development Team will take the
work it has completed thus far to the Kilimanjaro School
universal hplc analysis for counterfeit medication 25

of Pharmacy in Tanzania. Three students will travel to
the Kilimanjaro School of Pharmacy in August 2015.
The students will stay at the school for approximately
one week, where they will implement the project and
interact with the partners. Activities include constructing
one of the Agilent 1100 series HPLC units donated to the
team by Merck & Co., Inc., and upon successful setup
of this HPLC unit, the team will train members of the
Kilimanjaro School of Pharmacy on how to successfully
replicate the setup process. The team also will train
members of the school in how to run and troubleshoot
the standard and extraction methods developed for
amoxicillin, hydrochlorothiazide, lumefantrine,
mefloquine, and quinine.
Because the major aim of this project is to create a
universal method for detecting counterfeit medications,
it is desired to continue the work of this Global
Development Team at least into the 2015–2016
academic school year. Members of this team hope to
create methods to detect other commonly counterfeited
medications in Tanzania. By maintaining other
parameters of this project, such as limiting the number
of solvents used in the HPLC, this project will become
even more universal, allowing for the testing of as many
drugs as possible.
Future work will expand the method to include
more commonly used and commonly counterfeited
medications as well as to maintain training and
troubleshoot materials used at the Kilimanjaro School of
Pharmacy.
As mentioned previously, there are other very specific
means of detecting counterfeit drugs. This project aims
to eventually achieve a universal method for HPLC drug
analysis that will clearly identify drugs that are not as
they are labeled. If this goal is achieved, students and
faculty can be trained to identify counterfeit drugs. This
will result in rebuilding trust in pharmaceuticals, and,
most importantly, it will save lives.
FEEDBACK
If we were to begin again, we would make a few
changes. First, we would seek additional funding at the
start. The majority of the project funds came from a
single private campus laboratory. While these donations
were greatly appreciated, had we received more grants,
more solvents could have been purchased, along with a
single devoted laptop to make the project more efficient
and streamlined. Another important area of focus would
have been on early and increased communication with
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the Kilimanjaro School of Pharmacy. Learning what
supplies and resources they have access to, the best
way for us to teach them how to utilize our findings,
and more communication about the Tanzanian culture
all would have been very beneficial. There also have
been roadblocks for the team in regard to the HPLC
and computer utilization. Due to limited resources,
we had to share equipment with other groups in our
laboratory. Had we had a laptop and HPLC system
devoted to our team, we would have had more time
to complete relevant testing that otherwise was spent
waiting for an available instrument or restoring the
settings for our tests and methods. Finally, it would
have been beneficial for new members and returning
members to have comprehensive training on the
instrument during onboarding, as much of the training
was through self-learning and discovery.
EVALUATION
This project taught all of the project members many
invaluable lessons, with many more surely to follow.
Working with an analytical instrument has taught us
about a process used in research laboratories all over the
world. Learning how to troubleshoot computer problems
and fix problems as they arise is important in most
career paths. This project has given us an opportunity to
protect, improve, and save lives.
ACKNOWLEDGMENTS
Acknowledgment is provided to our service project
mentors Dr. Stephen Byrn and Dr. Kari Clase, and to our
writing mentor, Dr. Lalatendu Acharya.
REFERENCES
Bagozzi, D. (2003). Substandard and counterfeit medicines. WHO Media Centre.
Retrieved from http://www.who.int/mediacentre/factsheets/2003/fs275/en/
Dwortzan, M. (2013). Zaman’s PharmaCheck one of Scientific American’s ten world
changing ideas. Boston University Biomedical Engineering News. Retrieved from
http://www.bu.edu/phpbin/news-cms/news/?dept=666&id=60960
Karunamoorthi, K. (2014). The counterfeit antimalarial is a crime against
humanity: A systematic review of the scientific evidence. Malaria Journal, 13, 209.
http://dx.doi.org/10.1186%2F1475-2875-13-209
Rosenwald, M. (2013). How to detect counterfeit drugs. Popular Science. Retrieved
from http://www.popsci.com/science/article/2013-06/bad-medicine

McCord, J., Mavity, M., Damayo, S. A., & Wintczak, D.
(2015). Universal HPLC analysis for counterfeit
medication: A partnership of Purdue University and
the Kilimanjaro School of Pharmacy. Purdue Journal
of Service-Learning and Engagement, 2, 23–26. http://
dx.doi.org/10.5703/1288284315692

purdue journal of service-learning and international engagement: volume 2, fall 2015

